Abstract

Obesity in children is associated with vitamin D (VD) deficiency and cardiometabolic
abnormalities. To analyze the effects of VD supplementation in adolescents with obesity enrolled in a weight-loss program. Adolescents with obesity (n=26) and with normal weight (n=23; controls) were matched for age, sex, and puberty stage. The obesity group followed a 3-month weight-loss program that combined a reduced caloric intake with interval training physical activity and during which they received or not VD supplementation (4000 IU/d) (n=13/group; random assignation). The anthropometric parameters (BMI z-score, fat mass); serum levels of 25(OH)D, calcium and parathyroid hormone (PTH), cardiometabolic factors (triglycerides, HDL, and LDL cholesterol), fasting glucose and insulin, and homeostasis model assessment of insulin resistance index; diastolic, systolic and mean blood pressure, and inflammatory status (C-reactive protein, CRP) were measured at baseline and at the end of the 3-month program. At baseline, 25(OH)D concentration was lower and VD insufficiency (25(OH)D levels <50 nmol/L) rate was higher (73% vs 22%) in the obesity than in the normal-weight group. All cardiometabolic factors were altered in the obesity compared with the normal-weight group. After the 3-month weight-loss program, 25(OH)D levels was >50 nmol in all adolescents with obesity, but only in 46% of normal-weight adolescents.
Moreover, the weight-loss program improved the cardiometabolic factors, inflammatory status (CRP) and physical performance, but VD supplementation did not have any additional effect. Analysis only of the adolescents with obesity and VD deficiency (25(OH)D <50 nmol/L) at baseline showed a significant correlation between the change in PTH and CRP (p=0.02) in the supplemented obesity group, while the increase in 25(OH)D only tended to be correlated with CRP decrease. Vitamin D supplementation could reduce VD insufficiency in adolescent with obesity, but does not have any additional effect on cardiometabolic factors when combined with a weight-loss program.
Introduction
Vitamin D (VD) deficiency and obesity are two major health concerns worldwide [1] .The increasing prevalence of early childhood overweight and obesity raises major public health issues, and lifestyle measures need to be implemented to avoid comorbidities. Childhood obesity is strongly linked to cardiovascular risk factors, dyslipidemia, insulin sensitivity, inflammatory, and oxidative stress profiles [2] [3] . To date, few studies have investigated the potential positive effects of VD on the cardiometabolic risk factors in children and adolescents with obesity, with varying conclusions. Javed and al. [4] showed no effect of VD supplementation (2000 IU maximal dose) on insulin activity in non-diabetic adolescents with obesity without VD insufficiency. On the other hand, Belenchia and al. [5] found that 4000 IU VD3 corrected VD insufficiency and improved insulin sensitivity in adolescents with obesity.
The classical approach for weight management in childhood obesity includes diet and physical activity [6] [7] [8] . In children with obesity, weight-loss programs (diet and/or exercise training) reduce body fat mass and inflammation [9] improve insulin sensitivity, and also the lipid profile [10] [11] [12] . Moreover, two literature reviews concluded that weight management through diet alone or with physical activity leads to normalization of 25-hydroxyvitamin D (25(OH)D) level in adults with obesity [13] [14] . Data on childhood obesity are still limited [15] [16] . We hypothesized that a weight loss intervention combining also VD supplementation could result in additional health benefits in adolescents with obesity.
The present double-blind, randomized, placebo-controlled clinical study evaluated the possible added effects of VD supplementation on body composition, aerobic fitness, and cardiometabolic risk factors (e.g., blood pressure, insulin resistance, lipid and inflammation profiles) in adolescents with obesity enrolled in a weight-loss program that included diet and physical exercise.
Methods
Study population
Adolescents (12 to 17 years of age) with obesity were enrolled at a pediatric weight management clinic, whereas the age-, sex-, puberty stage-and season-matched controls with normal weight were volunteers (Fig. 1 ). As reported by Gutierrez-Medina et al [17] , the pubertal status should be taken into account when assessing obesity-related VD deficiency. Obesity was defined according to the age and sex-specific cut-off points of childhood obesity, as recommended by the International Obesity Task Force [18] . General exclusion criteria were: history or presence of premature cardiovascular or metabolic disease in a first-degree family member, active smoking, regular intake of any medication, pubertal status lower than Tanner stage 2, and not willing to take VD supplementation. Specific exclusion criteria were: weight loss higher than 5% of their total weight during the previous 3 months for adolescents with obesity, and body mass index (BMI) above the 90 th percentile for their sex and age for adolescents with normal weight. To minimize the potential moderating effect of physical activity, adolescents who participated in extra-school sport activities more than three hours per week were also excluded.
Study Design
Adolescents with obesity (n=36) who voluntarily accepted to follow a 3-month weight loss program (diet and exercise training) at a pediatric weight-management center were asked to participate in a double-blind, randomized, placebo-controlled clinical study, from April 2015
to shown that VD3 is equally bioavailable in orange juice and capsules [19] . The randomization list was generated with the SAS software, version 9.4. The inclusion of adolescents with obesity was managed with the INCLUSIO software, developed by Nimes University Hospital (France), and using a secure individual connection (login and password).
All adolescents with obesity followed the same moderately hypocaloric diet (reduction of 300 to 500 calories per day) based on a balanced intake of carbohydrates (55%), proteins (15%), and lipids (30% in total, with less than 10% of saturated fats) [16] . During the 3-month program, exercise training consisted in supervised moderate-to-vigorous intensity exercise for 180 min/week. Each session mostly involved aerobic exercise, including training circuit, boxing, basket-ball and Nordic walk, with alternating short periods of high-intensity exercise interspersed among periods of lower intensity, as previously described [20] .
The 23 healthy adolescents with normal weight were recruited from the community to serve as controls at baseline and after the 3-month program.
The study protocol was approved by the local Ethics Committee and was performed in accordance with the principles outlined in the Declaration of Helsinki. Informed consent was obtained from all adolescents and their parents.
Dietary assessment
All participants were asked to complete a three-day dietary record to assess the total energy dietary intake, and a food-frequency questionnaire containing calcium-and VD-related nutrients to determine their usual dietary intake pattern.
Outcome measures
Anthropometric data and body composition
Anthropometry and body composition were assessed at baseline and after the 3-month intervention. BMI was calculated as weight in kilograms divided by height in squared meters (kg.m -2 ). The BMI z-scores were also calculated. Adolescents with obesity underwent dualenergy X-ray absorptiometry (QDR 2000 -Discovery, Hologic, Bedford, MA) before and after the 3-month program, and controls only at baseline. Body fat mass and abdominal fat mass were reported [18] . Skin tone was categorized in light, medium and dark [3] .
Aerobic fitness test
Only adolescents with obesity performed the 20-meter shuttle run test [21] . (mU/L)/22.5) [23] . Hs-CRP, TNFα, IL-6, adiponectin and leptin were measured in serum samples using commercially available Elisa kits from R&D Systems (Minneapolis, USA), according to the manufacturer's specifications. For analysis of hs-CRP, adiponectin and leptin, serum samples were diluted 1:100 with sample diluent prior to analysis.
Statistical analysis
All statistical analyses were performed using the free R software (R 
Results
Baseline characteristics
At baseline, normal-weight controls and adolescents with obesity were matched for age, sex, and Tanner stage (Tables 1 and 2 nmol/L, p<0.05), and the rate of VD insufficiency (25(OH)D levels <50 nmol/L) was higher (73% vs 22%) in adolescents with obesity than in normal-weight controls. Although systolic and diastolic blood pressure (SBP and DBP) were higher and lower, respectively, in adolescents with obesity than in controls, no case of hypertension was reported (Table 1) .
Insulin, HOMA-IR and TG also were higher (+116%, +113% and +43%, respectively), HDL-C levels were lower (-33%), and the TG/HDL-C ratio was higher in adolescents with obesity than in controls. The mean of TG/HDL-C ratio in adolescents with obesity was higher than the cut-off previously defined as a metabolic syndrome indicator in children [26] . The insulin values in the obesity group were above the threshold (>100 pmol/L), defined as ''at risk'' by Delvin et al [27] . No significant difference was observed for calcium, resting heart rate, and LDL-C between groups. However, hs-CRP, IL-6 and leptin levels were higher and adiponectin levels were lower in adolescents with obesity than in controls. Comparison of the baseline characteristics in the OS and ONS groups (Table 2) showed that the clinical and metabolic variables were comparable between groups, but for PTH, DBP, insulin, and particularly the HOMA-IR index that was higher than 3.16 in the OS groups, suggesting insulin resistance [28] . 
Changes in clinical and metabolic variables after the 3-month intervention in the OS and ONS groups
As expected for lifestyle interventions, anthropometric variables (BMI, BMI z-score, fat mass and abdominal fat mass) were significantly and similarly reduced in both groups (OS and ONS) after the 3-month weight-loss program compared with baseline ( program, all cardiometabolic variables were improved in both groups. Although the HOMA-IR was strongly reduced in both groups (-45% in OS, p<0.001 and -34%, in ONS, p<0.001), it was still significantly different between groups. Indeed, it was below 3.16, the cut-off for insulin resistance [28] , in all adolescents of the ONS group, but only in the first quartile of the OS group. The lipid profiles were similarly improved in both groups with reduced TG (-41% and -22%, respectively), total cholesterol (-17% and -20%), and LDL-C (-27.5% and -26%) levels compared with baseline (p values <0.001 for all lipid variables), but for HDL-C. The intervention also reduced the inflammatory marker levels in both groups: hs-CRP (-17% and -59%, respectively; p = 0.046 between groups), TNF- (-14% and -18%), IL-6 (-34% and -47%; p=0.086 between groups) and leptin (-53% and -44%; p values <0.001).
Correlations between changes in 25(OH)D, PTH or PTH/25(OH)D ratio and cardiometabolic variables in adolescents with obesity and VD deficiency.
When the analysis was restricted to all the adolescents with obesity and baseline VD insufficiency (25(OH)D <50 nmol/L; n=18, 9 OS and 9 ONS), the change ( in 25(OH)D between baseline and the end of the intervention was strongly and negatively correlated with the TG/HDL-C ratio (r =-0.7, p<0.001). Similarly, the PTH/25(OH)D ratio was negatively correlated with the BMI z-score (r =-0.51, p<0.04), and SBP (r=-0.53, p 0.03). These correlations were maintained after adjusting for sex and skin tone (data not shown).
In the nine adolescents of the OS group, the strongest correlations were obtained between PTH and PTH/25(OH)D ratio and DBP (r= -0.86 p = 0.01) and MBP (r = -0.89 p <0.001). Moreover, PTH was correlated with CRP (p 0.02).
In the nine adolescents of the ONS group, PTH and PTH/25(OH)D ratio were not correlated with DBP or MBP. Conversely, PTH was significantly correlated with changes in glycemia and HOMA-IR, and PTH/25(OH)D ratio was correlated with the change in glycemia. These correlations were not found in the OS group.
Discussion
The present study confirms that pediatric obesity impairs many clinical and cardiometabolic variables. Notably, we found in adolescents with obesity enrolled in a lifestyle program a higher prevalence of insulin resistance, higher TG/HDL-C ratio and inflammatory status compared with adolescents with normal weight. An increase in the TG/HDL-C ratio can be used to predict increased arterial stiffness in young subjects who have developed obesity, as previously suggested [26] . In our study, the insulin and HOMA-IR values of adolescents with obesity were above the unfavorable thresholds established by Delvin et al [27] and Keskin et al [28] (i.e. >100 pmol/L and >3.16, respectively). As other previous cross-sectional studies [29] [30] [31] , low serum 25(OH)D concentrations were associated with obesity in adolescents.
In our study, 70% of adolescents with obesity had baseline 25(OH)-D concentrations lower than 50 nmol/L (equal to 20 ng/mL), which defines deficiency according to the French guidelines [32] . Obesity-related VD insufficiency could be explained by many factors: sun underexposure, inadequate intake of VD-rich foods and beverages, genetic factors [33] , Our finding that 25(OH)D levels as total and free were increased also in the ONS group after the 3-month lifestyle program suggests a possible release of VD during weight loss in the absence of VD supplementation. Previous studies also reported increased circulating 25(OH)D levels in adults with obesity after adiposity loss through lifestyle interventions without VD supplementation [14] . Note that our study was carried in the South of France from April to July, and the increased sun intensity/exposure during the spring/summer months could have contributed to endogenous VD biosynthesis. This hypothesis was validated by finding that the mean 25(OH)D level in the control group also was increased by 20% (data not shown) at the end of the same 3-month period. Nevertheless, satisfactory 25(OH)D plasma levels (close to 75 nmol/L) were observed only in the OS group at the end of the intervention, in accordance with studies reporting the efficacy and safety of 4000 IU VD [5] . Moreover, the significant decrease in PTH observed in our study with a dose of 4000 IU VD is in agreement with the results reported by Bhagatwala et al [38] in been associated with PTH decrease, and higher serum PTH concentration was linked to impaired endothelial function. This suggests that the circulating PTH level could be associated with higher hypertension risk through different potential molecular mechanisms [46] , and a reduction of the PTH/25(OH)D ratio could be taken as an indicator of reduced cardiovascular risk.
Our study did not find any additional effect of VD supplementation on glycemia and estimated insulin resistance expressed by HOMA-IR, while insulin sensitivity is improved by this intervention [47] . Our result is in agreement with an intervention trial (VD supplementation and resistance exercise training) in adults with overweight and obesity [48] .
The presence of a significant effect on glycemia and HOMA-IR also in the ONS group indicates that a lifestyle program can on its own improve glucose metabolism. A recent metaanalysis on different populations (adults, people with obesity, women…) showed that there is a non-linear association between VD status and fat mass percentage in a dose-effect analysis, without any beneficial effect with VD doses higher than 2000 UI [49] . This suggests that the high dose of VD used in our study could explain the absence of additional effects related to this supplementation. Future studies should evaluate the dose-effect relationship.
VD supplementation did not have any additional effect on lipid metabolism, in contrast with results previously reported in children with severe obesity, where 25(OH)D concentrations have been positively associated with HDL-C levels [50] .
Finally, although hs-CRP reduction was more important in the ONS group, we found a positive association between changes in PTH concentrations and in the PTH/25(OH)D ratio and changes in hs-CRP levels in the OS group (p=0.02 and 0.07 respectively). It has been reported that VD has anti-inflammatory actions [51] .
Our study has several limitations: the relatively small size of our cohort that included both girls and boys; only the OS group showed signs of insulin resistance at baseline; the use of a single-dose supplementation; and the assessment of serum parameters only at two time points.
Unfortunately, we did not measure the active metabolite 1,25(OH)2D and 25-hydroxylase activity, and also we did not assess the synthesis of vitamin D-binding proteins.
Our study protocol has also some strengths because dietary intake (VD, calcium), seasonality, and sun exposure time were the same in both OS and ONS groups. We controlled for the pubertal status because it may play a role in changes in BMI, lipid and glucose levels.
In conclusion, the combination of exercise, including recreational intermittent physical activities, and healthy diet has strong positive effects on different cardiometabolic parameters. 
